Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Envoy Medical (COCH) Total Liabilities (2022 - 2025)

Historic Total Liabilities for Envoy Medical (COCH) over the last 4 years, with Q3 2025 value amounting to $15.7 million.

  • Envoy Medical's Total Liabilities fell 4373.7% to $15.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.7 million, marking a year-over-year decrease of 4373.7%. This contributed to the annual value of $30.4 million for FY2024, which is 20237.88% up from last year.
  • Per Envoy Medical's latest filing, its Total Liabilities stood at $15.7 million for Q3 2025, which was down 4373.7% from $39.8 million recorded in Q2 2025.
  • Over the past 5 years, Envoy Medical's Total Liabilities peaked at $39.8 million during Q2 2025, and registered a low of $10.0 million during Q4 2023.
  • Its 4-year average for Total Liabilities is $23.9 million, with a median of $21.2 million in 2023.
  • In the last 5 years, Envoy Medical's Total Liabilities plummeted by 7407.29% in 2023 and then surged by 20237.88% in 2024.
  • Over the past 4 years, Envoy Medical's Total Liabilities (Quarter) stood at $38.8 million in 2022, then tumbled by 74.07% to $10.0 million in 2023, then skyrocketed by 202.38% to $30.4 million in 2024, then plummeted by 48.28% to $15.7 million in 2025.
  • Its Total Liabilities stands at $15.7 million for Q3 2025, versus $39.8 million for Q2 2025 and $34.6 million for Q1 2025.